New hormone treatment for polycystic ovary syndrome
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests a new medication that combines two hormone-like drugs to treat polycystic ovary syndrome (PCOS), a condition affecting ovulation and hormone balance. The trial aims to see if this dual-action drug can improve irregular periods and other PCOS symptoms better than current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female, between 18 and 40 years old
- You have PCOS diagnosed by at least 2 of these: very irregular periods, multiple small cysts on ovaries (seen on ultrasound), or high male hormone levels
- You are not planning to get pregnant for at least 2 months after the study ends, and you agree to use approved birth control
- You have not used hormone birth control pills, patches, or rings in the past 2 months
- You do not have type 1 or type 2 diabetes, a history of pancreas problems, or thyroid cancer in your family
- You have not had weight-loss surgery in the past year or taken GLP-1 drugs (like Ozempic, Wegovy) in the past year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a mobile app that guides you on a Mediterranean diet (rich in vegetables, fruits, whole grains, and healthy fats like olive oil) to see if it helps improve PCOS symptoms. You would follow the app's plan for a few months while researchers track your periods, hormones, and overall health.
This trial studies whether a team of doctors from different specialties can better diagnose and treat PCOS. If you have PCOS and are looking for a more comprehensive approach, this study may be a good fit.
This trial tests a medication called a GLP-1 agonist (a type of drug that helps with weight loss and blood sugar) to see if it can improve how your brain and reproductive system work, which may help with PCOS symptoms and fertility. The study is for teenage girls with PCOS who are also obese, and it could offer an option if lifestyle changes alone haven't been enough.
This trial tests whether a class of drugs called GLP-1 receptor agonists (often used for diabetes and weight loss) can improve pregnancy outcomes in women with polycystic ovary syndrome (PCOS) who are overweight or obese. If you have PCOS and a BMI between 28 and 35, you may be eligible to participate.
This study looks at hormone levels and metabolism in people who may have polycystic ovary syndrome (PCOS). It aims to better understand why PCOS happens, which could help improve future diagnosis and treatment.
This study looks at a tool to help diagnose polycystic ovary syndrome (PCOS) more accurately and guide treatment. PCOS is a common hormone problem that can cause irregular periods, extra hair, and other symptoms.
Hear when a new PCOS (Polycystic Ovary Syndrome) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.